Figure 2From: The biochemical aftermath of anti-amyloid immunotherapyWestern blots of GM homogenates. A total of 25 Ī¼g of protein was loaded in each lane. A) 22C11 against amino acid residues 66-81 of APP, B) CT9APP against the last nine amino acid residues of APP and C) tau HT7 against amino acid residues 159-163 of tau. For further details see the Results Section. IMZ, immunized; AD, Alzheimer's disease; NDC, non-demented control.Back to article page